Thus, serum S100B levels may be used as a promising marker to identify patients at increased risk of specific early neurological complications like hemorrhagic transformation after stroke and as an indicator of cerebral damage and functional outcome (Foerch et al., 2007). The gene discussed is S100B; the disease is Stroke.